Comment: prophylaxis for RSV hospitalization may not be cost-saving
Erasmus Universiteit Rotterdam, Rotterdam, South Holland, Netherlands Annals of Pharmacotherapy
(Impact Factor: 2.06).
04/2002; 36(3):534-5. DOI: 10.1345/aph.10374a
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.